RNAZ · Transcode Therapeutics, Inc.
$2.18
-0.10 (-4.39%)
At close · Aug 28
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Due to the Company's recurring and expected continuing losses from operations, the Company has concluded there is substantial doubt concerning its ability to continue as a going concern for one year after the issuance of these consolidated financial statements without additional capital becoming available.”View the 10-Q filed Aug 14, 2026
Market Cap
$36.42M
Shares
16.93M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-07-08 | 439 | $8.44 | $3,705 |
| 2026-07-02 | 1,253 | $7.65 | $9,585 |
| 2026-06-29 | 2,427 | $4.97 | $12,062 |
| 2026-06-18 | 3 | $5.35 | $16 |
| 2026-06-16 | 591 | $5.47 | $3,233 |
| 2026-06-12 | 24 | $5.69 | $137 |
| 2026-06-08 | 23,444 | $5.43 | $127,301 |
| 2026-06-05 | 168 | $5.84 | $981 |
| 2026-06-04 | 71,207 | $5.04 | $358,883 |
| 2026-06-03 | 1,820 | $5.30 | $9,646 |
Showing 1–10 of 10 settlements